The ALS clinical features
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a progressive neurodegenerative disorder that primarily affects nerve cells responsible for controlling voluntary muscle movements. The clinical features of ALS are varied and typically manifest gradually, making early diagnosis challenging. Understanding these features is essential for timely intervention and management.
Initially, patients often notice muscle weakness or clumsiness, especially in their hands or arms. This weakness may manifest as difficulty performing fine motor tasks, such as buttoning a shirt or writing. Over time, the weakness becomes more pronounced and spreads to other parts of the body. Muscle atrophy, or wasting, is a hallmark feature, resulting from the degeneration of motor neurons. Patients may observe visible thinning of muscles and a decrease in muscle tone, leading to a flaccid or “soft” appearance.
Another early sign involves fasciculations—muscle twitching that occurs spontaneously. These involuntary contractions are often visible beneath the skin and can be quite distressing. As the disease advances, patients may experience cramping and tightness in affected muscles, often accompanied by increased fatigue during movements.
A critical feature of ALS is the progressive weakness of muscles involved in speech, swallowing, and breathing. Patients may develop dysarthria, which results in slurred or nasal speech due to weakened muscles controlling speech articulation. Dysphagia, or difficulty swallowing, can lead to drooling, choking, and an increased risk of aspiration pneumonia. Respiratory muscle involvement is a late feature but a significant cause of morbidity, leading to shortness of breath and decreased respiratory capacity. Patients might experience wakefulness at night due to breathing difficulties or require ventilatory support as the disease progresses.
Interestingly, cognitive and behavioral changes can also appear in some ALS patients, particularly those with frontotemporal dementia. These changes may include im
paired judgment, apathy, disinhibition, or language difficulties, highlighting that ALS is not solely a motor neuron disorder.
Reflexes may be hyperactive or diminished depending on the disease stage and location of motor neuron degeneration. The presence of both upper motor neuron (UMN) signs, such as spasticity, hyperreflexia, and pathological reflexes (e.g., Babinski sign), along with lower motor neuron (LMN) signs like fasciculations, muscle weakness, and atrophy, is characteristic of ALS. This combination helps distinguish ALS from other neuromuscular conditions.
The clinical course of ALS is highly variable, but it generally progresses rapidly, with most patients facing significant functional decline within three to five years after onset. Despite the severity, the disease typically spares sensation, bladder, and bowel functions until very late stages, and intelligence remains intact in most cases.
In summary, ALS presents with a combination of motor symptoms including muscle weakness, atrophy, fasciculations, spasticity, and bulbar symptoms affecting speech and swallowing. Recognizing these clinical features early is vital for diagnosis, management, and providing patients and their families with appropriate support and care options.
